CD34 stem cell therapy (Ossium Health)

N/A

Report date: 2025/02/19 16:44:01

Base Information

Drug NameCD34 stem cell therapy (Ossium Health)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOssium Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesColumbia UniversityOssium Health Inc
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A